EUVIMEDEUVIMED entdecken
Crossref

UBP43 promotes epithelial ovarian carcinogenesis via activation of β ‐catenin signaling pathway

Hongyang Xie, Junyu Chen, Changyan Ma, Jingjing Zhao, Manhua Cui

Cell Biology International · 2023

DOI: 10.1002/cbin.12028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology International, 2023. Verfasst von Hongyang Xie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, Jilin Province, China. Hauptthemen laut MEDLINE: beta Catenin, Ovarian Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulation of the deubiquitinating protease, UBP43, has been implicated in many human diseases, including cancer. Here, we evaluated the functional significance and mechanism of action of UBP43 in epithelial ovarian cancer. We found that UBP43 was significantly upregulated in the tumor tissues of patients with epithelial ovarian cancer. Similar results were observed in OVCAR‐3, Caov‐3, TOV‐112D, A2780, and SK‐OV‐3 cells. Furthermore, in vitro functional assays of A2780 and TOV‐112D cells demonstrated that UBP43 overexpression promoted cell proliferation, migration, and invasion. Upregulation of UBP43 might result in epithelial–mesenchymal transition by inducing the nuclear transport of β‐catenin, which was accompanied by enhanced N‐cadherin but decreased E‐cadherin expression. These malignant phenotypes were reversed by UBP43 silencing. Further investigation revealed that the knockdown of UBP43 inhibited cell proliferation by inducing a cell cycle arrest at the G2/M phase. The oncogenic characteristics of UBP43 were validated in a subcutaneous xenograft mouse model. In vivo, tumor growth was delayed in the UBP43‐silenced group but accelerated after UBP43 overexpression. Finally, we demonstrated that β‐catenin is a key protein in the UBP43‐mediated malignant development of epithelial ovarian cancer. Specifically, overexpression of UBP43 decreased the ubiquitination degradation of β‐catenin and enhanced its protein stability. Also, we observed that the downstream genes of beta‐catenin such as cyclin D1, MMP2, and MMP9 were upregulated due to UBP43 overexpression. Thus, we concluded that UBP43 promoted epithelial ovarian cancer tumorigenesis and metastasis through activation of the β‐catenin pathway, suggesting that UBP43 may be a potential therapeutic target for this intractable disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta CateninOvarian NeoplasmsAnimalsFemaleHumansMiceApoptosisCarcinogenesisCarcinoma, Ovarian EpithelialCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticWnt Signaling PathwayUbiquitin Thiolesterase

Stichwörter der Autor:innen

UBP43cancer-promotingde-ubiquitinationepithelial ovarian cancerβ-catenin

Substanzen

beta CateninUSP18 protein, humanUbiquitin ThiolesteraseCTNNB1 protein, human

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, Jilin Province, China.

Zitieren

APA

Xie, H., Chen, J., Ma, C., Zhao, J., & Cui, M. (2023). UBP43 promotes epithelial ovarian carcinogenesis via activation of β ‐catenin signaling pathway. Cell Biology International. https://doi.org/10.1002/cbin.12028

Vancouver

Xie H, Chen J, Ma C, Zhao J, Cui M. UBP43 promotes epithelial ovarian carcinogenesis via activation of β ‐catenin signaling pathway. Cell Biology International. 2023. doi:10.1002/cbin.12028

BibTeX
@article{Xie2023,
  author = {Xie, Hongyang and Chen, Junyu and Ma, Changyan and Zhao, Jingjing and Cui, Manhua},
  title = {UBP43 promotes epithelial ovarian carcinogenesis via activation of β ‐catenin signaling pathway},
  journal = {Cell Biology International},
  year = {2023},
  doi = {10.1002/cbin.12028}
}
Kostenlos starten →